✦ LIBER ✦

158. Strategy for the treatment of acute promyelocytic leukemia combining differentiation agent and cytotoxic drugs

✍ Scribed by Degos, L; Castaigne, S; Daniel, MT; Pénaux, P

Book ID: 123368083
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 82 KB
Volume: 46
Category: Article
ISSN: 0753-3322
DOI: 10.1016/0753-3322(92)90243-Z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The catalytic DNA topoisomerase II inhib

The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: Candidate drugs for chemo-differentiation therapy against acute promyelocytic leukemia

✍ Nozomi Niitsu; Masaaki Higashihara; Yoshio Honma 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 456 KB

Characterization of the metabolic forms

Characterization of the metabolic forms of 6-thioguanine responsible for cytotoxicity and induction of differentiation of HL-60 acute promyelocytic leukemia cells

✍ Kimiko Ishiguro; Edward L. Schwartz; Alan C. Sartorelli 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 1017 KB

New Strategies for the Treatment of Acut

New Strategies for the Treatment of Acute Myelogenous Leukemia: Differentiation Induction—Present Use and Future Possibilities

✍ Øystein Bruserud; Bjørn Tore Gjertsen 📂 Article 📅 2000 🏛 AlphaMed Press 🌐 English ⚖ 56 KB

Integration of biochemical, cellular, an

Integration of biochemical, cellular, and animal pharmacology of antineoplastic agents to design new model drug combinations for treatment of acute leukemia

✍ Richard L. Momparler; David Derse 📂 Article 📅 1977 🏛 Elsevier Science 🌐 English ⚖ 618 KB

A comparative trial of daunorubicin, cyt

A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemia

✍ Wiernik, Peter H. ;Glidewell, Oliver J. ;Hoagland, H. Clark ;Brunner, Kurt W. ;S 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 767 KB

In this study 523 previously untreated patients with acute myelocytic leukemia were randomly allocated to induction therapy with daunorubicin 60 mg/M2 daily X 3, cytosine arabinoside and thioguanine 100 mg/M2 each every 12 hours until marrow hypoplasia was achieved, or a 5-day course of the three dr

Histone deacetylase inhibition in the tr

Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents

✍ Fredly, Hanne; Gjertsen, Bjørn; Bruserud, Øystein 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 271 KB